• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

Radiol Med . Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data

tetano

Editor, Senior Moderator
Radiol Med


. 2020 Sep 7.
doi: 10.1007/s11547-020-01272-1. Online ahead of print.
Baseline chest X-ray in coronavirus disease 19 (COVID-19) patients: association with clinical and laboratory data


Marco Gatti[SUP] 1 [/SUP], Marco Calandri[SUP] 2 [/SUP], Matteo Barba[SUP] 2 [/SUP], Andrea Biondo[SUP] 3 [/SUP], Carlotta Geninatti[SUP] 2 [/SUP], Stephanie Gentile[SUP] 3 [/SUP], Marta Greco[SUP] 3 [/SUP], Vittorio Morrone[SUP] 3 [/SUP], Clara Piatti[SUP] 2 [/SUP], Ambra Santonocito[SUP] 3 [/SUP], Sara Varello[SUP] 3 [/SUP], Laura Bergamasco[SUP] 4 [/SUP], Rossana Cavallo[SUP] 5 [/SUP], Rosario Di Stefano[SUP] 6 [/SUP], Franco Riccardini[SUP] 7 [/SUP], Adriana Boccuzzi[SUP] 8 [/SUP], Giorgio Limerutti[SUP] 9 [/SUP], Andrea Veltri[SUP] 2 [/SUP], Paolo Fonio[SUP] 3 [/SUP], Riccardo Faletti[SUP] 3 [/SUP]



Affiliations

Abstract

Purpose: To assess the reliability of CXR and to describe CXR findings and clinical and laboratory characteristics associated with positive and negative CXR.
Methods: Retrospective two-center study on consecutive patients admitted to the emergency department of two north-western Italian hospitals in March 2020 with clinical suspicion of COVID-19 confirmed by RT-PCR and who underwent CXR within 24 h of the swab execution. 260 patients (61% male, 62.8 ? 15.8 year) were enrolled. CXRs were rated as positive (CXR+) or negative (CXR-), and features reported included presence and distribution of airspace opacities, pleural effusion and reduction in lung volumes. Clinical and laboratory data were collected. Statistical analysis was performed with nonparametric tests, binary logistic regression (BLR) and ROC curve analysis.
Results: Sensitivity of CXR was 61.1% (95%CI 55-67%) with a typical presence of bilateral (62.3%) airspace opacification, more often with a lower zone (88.7%) and peripheral (43.4%) distribution. At univariate analysis, several factors were found to differ significantly between CXR+ and CXR-. The BLR confirmed as significant predictors only lactate dehydrogenase (LDH), C-reactive protein (CRP) and interval between the onset of symptoms and the execution of CXR. The ROC curve procedure determined that CRX+ was associated with LDH > 500 UI/L (AUC = 0.878), CRP > 30 mg/L (AUC = 0.830) and interval between the onset of symptoms and the execution of CXR > 4 days (AUC = 0.75). The presence of two out of three of the above-mentioned predictors resulted in CXR+ in 92.5% of cases, whereas their absence in 7.4%.
Conclusion: CXR has a low sensitivity. LDH, CRP and interval between the onset of symptoms and the execution of CXR are major predictors for a positive CXR.

Keywords: Chest X-ray; Coronavirus disease 2019 (COVID-19); Laboratory test; Real-time reverse transcriptase-polymerase reaction chain test (RT-PCR); Sensitivity; Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
 
Back
Top Bottom